Home

SAN DIEGO (Reuters) - A single treatment with gene therapy, an experimental technique for fixing faulty genes, has been shown to boost output of a vital blood clotting factor, possibly offering a long-term solution for people with hemophilia B.

Researchers said the same technology was also being studied as a treatment for hemophilia A, the far more common type of the ...

SILVER SPRING, Maryland (Reuters) - A new Affymax Inc drug won expert backing to treat anemia in patients with chronic kidney disease who are on dialysis.

A Food and Drug Administration advisory panel voted 15-1 on Wednesday, with one abstention, that peginesatide's benefits outweighed its risks for such patients.

If approved by the FDA, the once-monthly injection could capture a ...

(Reuters) - Amgen Inc, aiming to secure future sales of its flagship anemia drug Epogen as potential competition emerges, has reached new supply contracts with the two largest operators of U.S. kidney dialysis clinics.

The biotechnology company said in a regulatory filing on Friday it signed a seven-year contract to provide DaVita Inc with at least 90 percent of the ...

(Reuters) - Amgen Inc reached a seven-year contract to supply DaVita Inc with nearly all of the anemia drugs needed by the dialysis clinic operator, locking up nearly a third of the U.S. market for its flagship drug Epogen.

Amgen said in a regulatory filing that the contract, which runs through 2018, "provides for discount pricing and rebates."

The deal ...

LOS ANGELES (Reuters) - The Medicare federal health insurance program has confirmed plans to remove a requirement that kidney dialysis providers keep patient hemoglobin levels above a set minimum -- a move likely to reduce use of Epogen, the anemia drug sold by Amgen Inc.

In a statement on its web site on Tuesday, the agency issued a final rule to remove ...

CHICAGO (Reuters) - U.S. scientists have found a way to get mice with a form of sickle cell disease to make normal red blood cells, offering a potential new way to treat the blood disorder in people, they reported on Thursday.

Adults with sickle cell disease make mutant, sickle-shaped forms of hemoglobin, the protein in red blood cells that is ...

LOS ANGELES (Reuters) - The Medicare federal health insurance program has proposed removing its requirement that kidney dialysis providers keep patient hemoglobin levels above a set minimum, which could lead to lower use of Epogen, the anemia drug sold by Amgen.

The government health plan said last month that it had no plans to change its reimbursement terms for anemia drugs ...

CHICAGO (Reuters) - A second pivotal trial of ruxolitinib, developed by Incyte Corp and Novartis, met its goal of showing that the drug significantly reduces spleen size in myelofibrosis patients.

The rare, but potentially deadly, blood cancer is characterized by bone marrow failure, enlarged spleen and debilitating symptoms, including fatigue and pain.

The Phase 3 trial, known as COMFORT II, showed ...

CHICAGO (Reuters) - A drug that eases symptoms of sickle cell disease in older children is safe and effective to use for babies with the blood disorder and should become the new standard of care, U.S. researchers said on Thursday.

They said the generic drug hydroxyurea significantly reduced pain and other common complications in babies with the disease, including hospitalizations ...

A detainee held in connection with anti-regime protests in Bahrain died in prison on Sunday, the Gulf state's interior ministry said in a statement.

"A detainee who was a sickle cell patient died on Sunday morning at the detention centre," it said. The ministry's website identified the man as Hasan Jasem Makki, 39.

A ministry official said a ...